Cite
Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study.
MLA
Misra, Puneet, et al. “Serological Prevalence of SARS-CoV-2 Antibody among Children and Young Age Group (between 2 and 17 Years) in India: An Interim Result from a Large Multicentric Population-Based Seroepidemiological Study.” Journal of Family Medicine & Primary Care, vol. 11, no. 6, June 2022, pp. 2816–23. EBSCOhost, https://doi.org/10.4103/jfmpc.jfmpc_2274_21.
APA
Misra, P., Kant, S., Guleria, R., Rai, S., Kishore, S., Baidya, S., Singh, A., Chinnakali, P., Medigeshi, G., Chaturvedi, P., Joshi, H., Mandal, S., Sangral, M., Yadav, K., Bairwa, M., Haldar, P., Kardam, P., Patil, S., & Jha, S. (2022). Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study. Journal of Family Medicine & Primary Care, 11(6), 2816–2823. https://doi.org/10.4103/jfmpc.jfmpc_2274_21
Chicago
Misra, Puneet, Shashi Kant, Randeep Guleria, Sanjay Rai, Surekha Kishore, Subrata Baidya, Arvind Singh, et al. 2022. “Serological Prevalence of SARS-CoV-2 Antibody among Children and Young Age Group (between 2 and 17 Years) in India: An Interim Result from a Large Multicentric Population-Based Seroepidemiological Study.” Journal of Family Medicine & Primary Care 11 (6): 2816–23. doi:10.4103/jfmpc.jfmpc_2274_21.